Mental illness and substance use: An Australian perspective

International Journal of Mental Health Nursing

Volumn 17, Issue 4, 2008, Pages 255-260

  Munro, Ian ^a   Edward, Karen Leigh ^a  

^a DEAKIN UNIVERSITY   (Australia)

Author keywords

Co morbidity; Dual diagnosis; Mental illness; Substance use

Indexed keywords

ADDICTION; AUSTRALIA; CLINICAL COMPETENCE; COMORBIDITY; COOPERATION; DRUG DEPENDENCE TREATMENT; EDUCATION; HEALTH SERVICE; HUMAN; MASS SCREENING; MENTAL DISEASE; MENTAL HEALTH SERVICE; NURSE ATTITUDE; NURSING ASSESSMENT; ORGANIZATION AND MANAGEMENT; PATIENT CARE; PREVALENCE; PROGNOSIS; PSYCHIATRIC DIAGNOSIS; PSYCHIATRIC NURSING; REVIEW; TOTAL QUALITY MANAGEMENT;

AUSTRALIA; CLINICAL COMPETENCE; COMORBIDITY; CONTINUITY OF PATIENT CARE; COOPERATIVE BEHAVIOR; DIAGNOSIS, DUAL (PSYCHIATRY); HEALTH SERVICES NEEDS AND DEMAND; HUMANS; MASS SCREENING; MENTAL DISORDERS; MENTAL HEALTH SERVICES; NURSE'S ROLE; NURSING ASSESSMENT; PREVALENCE; PROGNOSIS; PSYCHIATRIC NURSING; SUBSTANCE ABUSE TREATMENT CENTERS; SUBSTANCE-RELATED DISORDERS; TOTAL QUALITY MANAGEMENT;

EID: 46749123106     PISSN: 14458330     EISSN: 14470349     Source Type: Journal    
DOI: 10.1111/j.1447-0349.2008.00541.x     Document Type: Review

References (42)

1. Abou-Saleh, M. T. (2004). Psychopharmacology of substance misuse and co-morbid psychiatric disorders. Acta Neuropsychiatrica, 16, 19 25.
2. Addington, J. Addington, D. (2007). Patterns, predictors and impact of substance use in early psychosis: A longitudinal study. Acta Psychiatrica Scandinavica, 115 (4 304 309.
3. Baker, A. Dawe, S. (2005). Amphetamine use and co-occurring psychological problems: Review of the literature and implications for treatment. Australian Psychologist, 40 (2 87 94.
4. Baker, A., Bucci, S., Lewin, T. J., Kay-Lambkin, F., Constable, P. M. Carr, V. J. (2006). Cognitive-behavioural therapy for substance use disorders in people with psychotic disorders: Randomised controlled trial. British Journal of Psychiatry, 188 (5 439 448.
5. Baker, A., Lee, N., Claire, M. et al 2005). Brief cognitive behavioural interventions for regular amphetamine users: A step in the right direction. Addiction, 100 (3 367 378.
6. Barnes, L. Rudge, T. (2003). Co-operation and co-morbidity: Managing dual diagnosis in rural South Australia. Collegian, 10 (2 25 28.
7. Barnett, J. H., Werners, U., Secher, S. M. et al 2007). Substance use in a population-based clinic sample of people with first-episode psychosis. The British Journal of Psychiatry: The Journal of Mental Science, 190, 515 520.
8. Barrowclough, C., Haddock, G., Tarrier, N. et al 2001). Randomized controlled trial of motivational interviewing, cognitive behaviour therapy, and family intervention for patients with co-morbid schizophrenia and substance use disorders. American Journal of Psychiatry, 158 (10 1706 1713.
9. Carey, M. P., Carey, K. B. Meisler, A. W. (1991). Psychiatric symptoms in mentally ill chemical abusers. Journal of Nervous and Mental Disease, 179 (3 136 138.
10. Commonwealth of Australia (2004). The National Drug Strategy: Australia's Integrated Framework 2004-2009 (Commonwealth of Australia). Canberra, Australia: Ministerial Council on Drug Strategy-Commonwealth of Australia.
11. Croton, G. (2005). Australian treatment system's recognition of and response to co-occurring mental health & substance use disorders: Submission to the 2005 Senate Select Committee on Mental Health. [Cited 17 Sep 2007]. Available from URL: [ http://www.aph.gov.au/Senate/committee/mentalhealth_ctte/ submissions/sublist.htm ]
12. Deans, C. Soar, R. (2005). Caring for clients with dual diagnosis in rural communities in Australia: The experience of mental health professionals. Journal of Psychiatric and Mental Health Nursing, 12 (3 268 274.
13. Department of Human Services (2007). Dual Diagnosis - Key Directions and Priorities for Service Development. Melbourne: Victorian Government Department of Human Services.
14. Drake, R., Essock, S., Shaner, A. et al 2001). Implementing dual diagnosis services for clients with severe mental illness. Psychiatric Services, 52 (4 469 476.
15. Drake, R., Essock, S., Shaner, A. et al 2004). Implementing dual diagnosis services for clients with severe mental illness. Focus, 2 (1 102 110.
16. Drake, R., McHugo, G. J., Xie, H., Fox, M., Packard, J. Helmstetter, B. (2006). Ten-year recovery outcomes for clients with co-occurring schizophrenia and substance use disorders. Schizophrenia Bulletin, 32 (3 464 473.
17. Drake, R., Mercer-McFadden, C., Mueser, K. T. et al 1998). Review of integrated mental health and substance abuse treatment for patients with dual disorders. Schizophrenia Bulletin, 24, 589 608.
18. Dunckel, N. Vocational and (Calgary Alberta) Dept. of Research (1989). Dual Diagnosis (Mental Illness and Mental Handicap): An Overview, VRRI Research; 344. Calgary, AB: The Vocational and Rehabilitation Research Institute Dept. of Research.
19. Farrelly, S., Harris, M. G., Henry, L. P. et al 2007). Prevalence and correlates of co-morbidity 8 years after a first psychotic episode. Acta Psychiatrica Scandinavica, 116 (1 62 70.
20. Frisher, M., Collins, J., Millson, D., Crome, I. Croft, P. (2004). Prevalence of co-morbid psychiatric illness and substance abuse in primary care in England and Wales. Journal of Epidemiology and Community Health, 58 (12 1036 1041.
21. Hall, W., Darke, S., Ross, M. Wodak, A. (1993). Patterns of drug use and risk-taking among injecting amphetamine and opioid drug users in Sydney, Australia. Addiction, 88 (4 509 516.
22. Hall, W., Lynskey, M. Teeson, M. (2002). What is co-morbidity and why does it matter? Sydney: National Drug and Alcohol Research Centre, University of New South Wales. [Cited 4 Jun 2007]. Available from URL: [ http://www. nationaldrugstrategy.gov.au/new/pdf/whatis.pdf ]
23. James, W., Preston, N. J., Koh, G., Spencer, C., Kisely, S. R. Castle, D. J. (2004). A group intervention which assists patients with dual diagnosis reduce their drug use: A randomized controlled trial. Psychological Medicine, 34 (6 983 990.
24. Jenner, L. McKetin, R. (2004). Prevalence and patterns of psychostimulant use. In: A. Baker, N. K. Lee L. Jenner (Eds). Models of Intervention and Care for Psychostimulant Users pp. 13 34). National Drug Strategy Monograph Series no. 51 Canberra: Australian Government Department of Health and Ageing.
25. Judd, P. H., Thomas, N., Schwartz, T., Outcalt, A. Hough, R. (2003). A dual diagnosis demonstration project: Treatment outcomes and cost analysis. Journal of Psychoactive Drugs, 35 (Suppl. 1 181 192.
26. Kavanagh, D. J., Greenaway, L., Jenner, L. et al 2000). Contrasting views and experiences of health professionals on the management of co-morbid substance misuse and mental disorders. The Australian and New Zealand Journal of Psychiatry, 34 (2 279 289.
27. McDermott, F. Pyett, P. (1993). Not Welcome Anywhere, People who have both a Serious Psychiatric Disorder and Problematic Drug or Alcohol Use. Melbourne: Victorian Community Managed Mental Health Services.
28. McGovern, M. P., Clark, R. E. Samnaliev, M. (2007). Co-occurring psychiatric and substance use disorders: A multi-state feasibility study of the quadrant model. Psychiatric Services, 58 (7 949 954.
29. McKetin, R., McLaren, J., Lubman, D. Hides, L. (2006). The prevalence of psychotic symptoms among methamphetamine users. Addiction, 101 (10 1473 1478.
30. Macleod, J., Oakes, R., Copello, A. et al 2004). Psychological and social sequelae of cannabis and other illicit drug use by young people: A systematic review of longitudinal, general population studies. The Lancet, 363 (9421 1579 1588.
31. Miles, H., Johnson, S., Amponsah-Afuwape, S., Finch, E., Leese, M. Thornicroft, G. (2003). Characteristics of subgroups of individuals with psychotic illness and a comorbid substance use disorder. Psychiatric Services, 54 (4 554 561.
32. Miller, W. Rollnick, S. (1991). Motivational Interviewing: Preparing People to Change Addictive Behaviour. New York: Guildford.
33. Moore, T., Zammit, S., Lingford-Hughes, A. et al 2007). Cannabis use and risk of psychotic or affective mental health outcomes: A systematic review. The Lancet, 370 (9584 319.
34. Rassool, G. H. (2002). Dual Diagnosis: Substance Misuse and Psychiatric Disorders. London: Blackwell Science.
35. Regier, D., Farmer, M., Rae, D. et al 1990). Co-morbidity of mental disorders with alcohol and other drug abuse: Results from the Epidemiologic Catchment Area (ECA) study. Journal of the American Medical Association, 264 (19 2511 2518.
36. Sitharthan, T., Singh, S., Kranitis, P., et al 1999). Integrated drug and alcohol intervention: Development of an opportunistic intervention program to reduce alcohol and other substance use in psychiatric patients. Australian and New Zealand Journal of Psychiatry, 33, 676 683.
37. Teesson, M., Hall, W., Lynskey, M. Degenhardt, L. (2000). Alcohol- and drug-use disorders in Australia: Implications of the National Survey of Mental Health and Wellbeing. Australian and New Zealand Journal of Psychiatry, 34 (2 206 213.
38. Thornicroft, G. Betts, V. (2002). International Mid-term Review of the Second National Mental Health Plan for Australia. Mental Health and Special Programs Branch. Canberra: Department of Health and Ageing.
39. Topp, L., Day, C. Degenhardt, L. (2003). Changes in patterns of drug injection concurrent with a sustained reduction in the availability of heroin in Australia. Drug & Alcohol Dependence, 70, 275 286.
40. United Nations Office on Drugs and Crime (2007). World Drug Report. New York: United Nations Office on Drugs and Crime.
41. Woody, G., McLellan, A., Luborsky, L. O'Brien, C. (1985). Sociopathy and psychotherapy outcome. Archives of General Psychiatry, 42 (11 1081 1086.
42. World Health Organization (2007). Lexicon of alcohol and drug terms published by the World Health Organization. The World Health Organization. [Cited 4 Jul 2007]. Available from URL: [ http://wwwint/substance_abuse/ terminology/who_lexicon/en/ ]